Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	50.19	55.14	97.47	79.51	164.89
Short-Term Investments	285.88	202.96	326.68	446.73	285.61
Cash & Short-Term Investments	336.08	258.11	424.15	526.24	450.5
Cash Growth	30.21%	-39.15%	-19.40%	16.81%	50.48%
Accounts Receivable	84.76	69.02	51.13	52.75	138.91
Other Current Assets	129.65	26.44	32.56	48.89	22.55
Total Current Assets	550.49	353.57	507.85	627.87	611.96
Net Property, Plant & Equipment	112.55	105.55	83.46	81.35	62.29
Other Intangible Assets	133.28	134.98	143.05	150.64	35.91
Goodwill	25.08	22.06	22.06	143.03	50.9
Long-Term Investments	369.27	570.35	444.01	339.03	507.01
Other Long-Term Assets	22.86	33.46	34.9	44.12	10.65
Total Assets	1,214	1,220	1,235	1,386	1,279
Accounts Payable	18.65	18.36	15.36	23.09	20.49
Accrued Expenses	34.06	24.28	30.74	24.98	18.48
Current Portion of Long-Term Debt	0.48	0.41	1.18	5.64	6.15
Unearned Revenue	31.78	29.84	25.57	14.09	34.38
Other Current Liabilities	-	-	0.16	20.3	25.82
Total Current Liabilities	84.97	72.9	73.02	88.11	105.31
Other Long-Term Liabilities	21.84	17.91	29.02	28.07	7.53
Total Long-Term Liabilities	21.84	17.91	29.02	28.07	7.53
Total Liabilities	106.81	90.81	102.04	116.18	112.84
Common Stock	0	0	0	0	0
Additional Paid-in Capital	574.52	543.13	501.72	486.59	501.91
Accumulated Other Comprehensive Income	7.51	-0.37	1.21	-20.9	-0.76
Retained Earnings	529.95	590.47	633.18	801	657.6
Total Common Shareholders' Equity	1,112	1,133	1,136	1,267	1,159
Minority Interest	-5.27	-4.07	-2.82	3.19	7.13
Shareholders' Equity	1,107	1,129	1,133	1,270	1,166
Total Liabilities & Equity	1,214	1,220	1,235	1,386	1,279
Total Debt	0.48	0.41	1.18	5.64	6.15
Net Cash (Debt)	335.6	257.69	422.97	520.6	444.35
Net Cash Growth	30.23%	-39.07%	-18.75%	17.16%	48.43%
Net Cash Per Share	10.90	8.52	14.20	16.81	14.35
Book Value	1,112	1,133	1,136	1,267	1,159
Book Value Per Share	36.13	37.48	38.14	40.91	37.41
Tangible Book Value	953.63	976.2	970.99	973.02	1,072
Tangible Book Value Per Share	30.99	32.29	32.60	31.42	34.61

Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q